Updated:
Asahi Kasei Medical Co.
Asahi Kasei Medical Co. is a wholly-owned operating subsidiary of Asahi Kasei Corporation, a diversified Japanese chemical and materials conglomerate...
Asahi Kasei Medical Co.
Asahi Kasei Medical Co. is a wholly-owned operating subsidiary of Asahi Kasei Corporation, a diversified Japanese chemical and materials conglomerate founded in 1931. The company was established to produce medical devices and bioprocess equipment, leveraging the parent's membrane technology expertise. Wealth origin traces to the industrial growth of Asahi Kasei, not a single family. Strategy focuses on therapeutic apheresis, dialysis, and biopharmaceutical purification. The company manufactures plasmapheresis membranes, continuous renal replacement therapy machines, and virus removal filters used by drugmakers. It operates manufacturing and R&D facilities in Japan and maintains US offices for commercial and regulatory presence. Confirmed products include the Plasauto Σ dialyzer series. The footprint spans North America, Europe, and Asia. The parent company, Asahi Kasei Corporation, reported revenue exceeding $20 billion in fiscal 2022 (per Asahi Kasei annual report, 2023). Asahi Kasei Medical Co. represents the healthcare division, which contributed roughly 15% of total revenue. No separate AUM or external investment activity is disclosed for this subsidiary. A structural differentiator is its role as an operating company tied to an industrial conglomerate, not a traditional family office or asset manager. It manufactures and sells medical devices rather than deploying capital. Governance falls under the Asahi Kasei corporate structure, with no succession or family wealth management component.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
United States
City
Princeton, Wilmington, Bothell
Corporate office
Princeton, NJ, United States
Additional offices
Wilmington, MA, United States · Bothell, WA, United States · Japan
Sector focus
Frequently asked questions
Is Asahi Kasei Medical Co. a family office or investment firm?
No. Asahi Kasei Medical Co. is a medical device and bioprocess manufacturing subsidiary of Asahi Kasei Corporation, a Japanese industrial conglomerate. It does not manage external capital or operate as an asset manager. The company's role is operational—producing plasmapheresis membranes, dialysis equipment, and virus filters for pharmaceutical use.
What does Asahi Kasei Medical Co. actually manufacture?
The company manufactures blood purification equipment used in therapeutic apheresis and dialysis, including membranes and filters. It also produces virus removal filters and bioprocess components for biopharmaceutical manufacturing, leveraging the parent company's membrane filtration expertise.
How does Asahi Kasei Medical Co. relate to the larger Asahi Kasei Corporation?
It is a wholly-owned operating subsidiary of Asahi Kasei Corporation, a Tokyo-based conglomerate with businesses in chemicals, electronics, and housing. Asahi Kasei Medical represents the healthcare division. The parent company's revenue was over $20 billion in fiscal 2022 (per Asahi Kasei annual report, 2023).
Where does the underlying wealth of Asahi Kasei Medical Co. come from?
Wealth originates from the Asahi Kasei Corporation's industrial operations, not a single family. Asahi Kasei was founded in 1931 as an ammonia producer and grew into a diversified chemicals and materials group. The medical subsidiary is funded through corporate allocations, not family wealth.
Does Asahi Kasei Medical Co. have any investment portfolio or external capital commitments?
No publicly disclosed investment portfolio or external capital commitments. The company operates as a manufacturing entity, not an investment vehicle. It does not report AUM, fund commitments, or direct co-investment activity in public filings.
Where are Asahi Kasei Medical Co.'s main offices?
The company has offices in Princeton, New Jersey; Wilmington, Massachusetts; Bothell, Washington; and Japan. These locations support commercial, manufacturing, and R&D operations.
What therapeutic areas does Asahi Kasei Medical Co. focus on?
Primary focus areas include blood purification for kidney disease and sepsis, therapeutic apheresis for autoimmune disorders, and biopharmaceutical manufacturing. Products target dialysis, continuous renal replacement therapy, and virus removal in drug production.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: